Senior Director, New Ventures & Transactions, Neuroscience
Lilian is New Ventures and Transactions lead for Neuroscience, for Johnson & Johnson Innovation. Lilian is responsible for supporting the Neuroscience Therapeutic Areas Leads in identifying and transacting on important new opportunities as well as helping to manage the existing portfolio
Lilian has over 16 years’ experience in Medicinal Chemistry gained through working in both large pharma and CRO environments. Before joining Johnson & Johnson Innovation, Lilian was Senior Director of Chemistry at Charles River (Argenta). In this role, he co-headed of the chemistry department and was the Collaboration Leader of a large multidisciplinary tri-party partnership overseeing the delivery of multiple drug discovery projects. Prior to that, Lilian spent 13 years at AstraZeneca advancing in various leadership roles culminating as a Principal Scientist. During his time at AstraZeneca, Lilian gained extensive experience in lead optimization, lead identification and library design and synthesis.
Lilian received his postgraduate degree in Molecular and Supramolecular Organic Chemistry and his Ph.D. in Organic Chemistry from Louis Pasteur University. He was a Post-Doctoral Fellow at the University of York. Over the years, he has been involved in the successful delivery of nine clinical candidates, 3 of which are still in clinical evaluation. Lilian is the author and co-author of 71 publications and patents, and of a book on Medicinal Chemistry.